Seeking Alpha · HERO · October 23, 2026

Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials Transcript

Get the app for more

Explore stock news, insights and company research.